Table 2.

Relative co-localization area calculated for AnxA6, AnxA2 or FetuA vs. TNAP or β-actin in hFOB 1.19 or Saos-2 cells in resting conditions (R) or after stimulation with AA and β-GP (S). Data are means ± s.e., n = 3 measurements of three independent experiments (* p < 0.05 and ** p < 0.01).

	Inhibitor Type	Protein Type	Relative Co-Localization Area (%)
			hFOB 1.19 Cells		Saos-2 Cells
R	-	AnxA6/TNAP	12.93 ± 1.49		12.60 ± 0.88
		AnxA2/TNAP	10.86 ± 1.55		16.59 ± 1.20
		FetuA/TNAP	12.51 ± 2.11		16.61 ± 1.84
		FetuA/β-actin	13.40 ± 1.79		9.03 ± 0.43
	Lev	AnxA6/TNAP	31.72 ± 3.65		17.93 ± 0.83
		FetuA/β-actin	33.33 ± 4.61		14.69 ± 2.28
	K201	AnxA6/TNAP	19.46 ± 1.39		24.37 ± 4.26
		FetuA/β-actin	20.87 ± 0.68		12.82 ± 0.67
S	-	AnxA6/TNAP	17.40 ± 1.21		22.54 ± 1.49
		AnxA2/TNAP	16.03 ± 2.33		21.98 ± 5.09
		FetuA/TNAP	17.79 ± 0.46		22.23 ± 3.78
		FetuA/β-actin	18.24 ± 0.79		11.90 ± 1.53
	Lev	AnxA6/TNAP	24.27 ± 3.43		21.57 ± 1.54
		FetuA/β-actin	21.68 ± 0.20		19.23 ± 0.69
	K201	AnxA6/TNAP	16.02 ± 0.96		18.39 ± 1.31
		FetuA/β-actin	14.59 ± 2.87		23.25 ± 4.90